Cough, cold and allergy (hay fever) remedies continues to see a sharp deceleration in retail value sales growth during 2021 due to the impact of COVID-19. Indeed, cough, cold and allergy (hay fever) remedies is the most affected OTC category in 2021.
Current retail value sales growth of antihistamines/allergy remedies (systemic) is one of the least affected categories during 2021, although sales growth is still slightly negative. Sales of these products are tied to seasonal allergies which usually begin to pick up in February in preparation for the beginning of spring; but in 2021, this seasonal effect was much weaker than usual.
GSK Consumer Healthcare, US Pharmacia Sp zoo, Bionorica GmbH and Sandoz Pharmaceuticals dd remain the leading players in cough, cold and allergy (hay fever) remedies during 2021. All of these players benefit from economies of scale in research and development, manufacturing and marketing.
Cough, cold and allergy (hay fever) remedies is expected to see robust constant retail value sales growth during the forecast period. The main reason is likely to be the end of the pandemic and Lithuanians going out more often as a result, whether to work or socialise.
Antiviral medicine to moderate COVID-19 symptoms are currently being developed and more are likely to be developed during the forecast period. Should these drugs be assigned to cough, cold and allergy (hay fever) remedies, it is likely that the category will experience significant sales growth.
While chemists/pharmacists continue to dominate distribution of cough, cold and allergy (hay fever) remedies, e-commerce is a small, but emerging channel. Even before the onset of COVID-19, it accounted for larger growth of value sales than grocery retailers, and the pandemic has given it a further boost: With consumers forced to spend more time at home, they are turning to e-commerce in growing numbers.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Lithuania with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Lithuania, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Cough, Cold and Allergy (Hay Fever) Remedies
This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page